Piotr Lewczuk

Piotr Lewczuk

UNVERIFIED PROFILE

Are you Piotr Lewczuk?   Register this Author

Register author
Piotr Lewczuk

Piotr Lewczuk

Publications by authors named "Piotr Lewczuk"

Are you Piotr Lewczuk?   Register this Author

100Publications

2075Reads

47Profile Views

Digit ratio (2D:4D) and academic success as measured by achievement in the academic degree "Habilitation".

PLoS One 2019 25;14(2):e0212167. Epub 2019 Feb 25.

Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0212167PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388918PMC
November 2019

Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease.

J Geriatr Psychiatry Neurol 2019 Jul 24;32(4):211-220. Epub 2019 Apr 24.

1 Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0891988719841728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552296PMC
July 2019

Microvesicles from cerebrospinal fluid of patients with Alzheimer's disease display reduced concentrations of tau and APP protein.

Sci Rep 2019 May 8;9(1):7089. Epub 2019 May 8.

Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-43607-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506501PMC
May 2019

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.

Alzheimers Res Ther 2019 04 22;11(1):34. Epub 2019 Apr 22.

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13195-019-0485-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477717PMC
April 2019

Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.

Alzheimers Res Ther 2019 01 5;11(1). Epub 2019 Jan 5.

Department of Neurodegeneration Diagnostics, Medical University of Białystok, Białystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13195-018-0456-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320577PMC
January 2019

Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects.

J Alzheimers Dis 2019 ;68(3):1151-1159

Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-180563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484252PMC
January 2019

Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease.

J Alzheimers Dis 2019 ;69(2):551-559

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-190067DOI Listing
January 2019

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.

Alzheimers Dement 2018 10 23;14(10):1313-1333. Epub 2018 Jun 23.

Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2018.05.008DOI Listing
October 2018

CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD.

Ann Clin Transl Neurol 2018 Jul 26;5(7):883-887. Epub 2018 May 26.

Clinical Dementia Center Department of Neurology University Medical School Göttingen Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/acn3.584
Publisher Site
http://dx.doi.org/10.1002/acn3.584DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043772PMC
July 2018

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

World J Biol Psychiatry 2018 06 27;19(4):244-328. Epub 2017 Oct 27.

a Department of Psychiatry and Psychotherapy , Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg , Erlangen , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15622975.2017.1375556DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916324PMC
June 2018

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.

Int J Mol Sci 2018 06 27;19(7). Epub 2018 Jun 27.

Department of Neurodegeneration Diagnostics, Medical University of Białystok, 15-089 Białystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms19071884DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073792PMC
June 2018

A Specific Reduction in Aβ vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer's Disease From Meningitis and Multiple Sclerosis.

Front Aging Neurosci 2018 24;10:152. Epub 2018 May 24.

Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnagi.2018.00152DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976781PMC
May 2018

Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.

J Alzheimers Dis 2017 ;55(2):813-822

The Knight Alzheimer's Disease Research Center, Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-160722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147502PMC
February 2018

Amyloid β oligomers (AβOs) in Alzheimer's disease.

J Neural Transm (Vienna) 2018 02 1;125(2):177-191. Epub 2017 Dec 1.

Department of Neurodegeneration Diagnostics, Medical University of Białystok, Białystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-017-1820-xDOI Listing
February 2018

Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.

Heart Vessels 2017 Nov 31;32(11):1304-1313. Epub 2017 May 31.

Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Cardiology and Angiology, Erlangen University Hospital, Ulmenweg 18, 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00380-017-0998-zDOI Listing
November 2017

Excessive daytime sleepiness in a patient with coexisting myotonic dystrophy type 1, myasthenia gravis and Graves' disease.

Neurol Neurochir Pol 2017 Mar - Apr;51(2):190-193. Epub 2017 Feb 3.

Department of Neurology, Medical University of Bialystok, Bialystok, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pjnns.2017.01.007DOI Listing
August 2017

CSF Aβ - an excellent but complicated Alzheimer's biomarker - a route to standardisation.

Clin Chim Acta 2017 Apr 20;467:27-33. Epub 2016 May 20.

Inst. of Neuroscience and Physiology Dept. of Psychiatry and Neurochemistry The Sahlgrenska Academy at University of Gothenburg Mölndal, Sweden; Clinical Neurochemistry LaboratorySahlgrenska University Hospital, MölndalSE-431 80 Mölndal Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2016.05.014DOI Listing
April 2017

Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.

Alzheimers Dement 2017 01 18;13(1):45-58. Epub 2016 Nov 18.

AXA Research Fund and UPMC Chair, Paris, France; Department de Neurologie, Institut de la Memorie et de la Maladie d'Alzheimer (IM2A) et Institut du Cerveau et du la Moelle epiniere (ICM), Hospital de la Pitie-Salpetriere, Sorbonne Universites, Universite Pierre et Marie Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2016.09.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218961PMC
January 2017

Do we still need positron emission tomography for early Alzheimer's disease diagnosis?

Brain 2016 11;139(11):e60

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/aww168DOI Listing
November 2016

Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta.

J Neurochem 2016 10 30;139(2):324-332. Epub 2016 Sep 30.

Department of Psychiatry, Division of Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jnc.13766DOI Listing
October 2016

Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays.

J Alzheimers Dis 2015 ;43(1):183-91

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-140771DOI Listing
January 2016

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.

Alzheimers Res Ther 2015 Dec 24;7:74. Epub 2015 Dec 24.

Department of Psychiatry and Psychotherapy, University clinic Erlangen and Friedrich-Alexander University Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13195-015-0161-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690296PMC
December 2015

Application of multiplexing technology to the analysis of the intrathecally released immunoglobulins against B. burgdorferi antigens in neuroborreliosis.

Immunol Lett 2015 Nov 22;168(1):58-63. Epub 2015 Jul 22.

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2015.07.001DOI Listing
November 2015

Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease.

J Alzheimers Dis 2015 ;43(3):1031-7

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-141050DOI Listing
August 2015

Surface Trafficking of APP and BACE in Live Cells.

Traffic 2015 Jun 14;16(6):655-75. Epub 2015 Apr 14.

Department of Psychiatry and Psychotherapy, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tra.12270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680167PMC
June 2015

Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.

J Alzheimers Dis 2014 ;41(4):1057-62

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-132708DOI Listing
March 2015

Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective.

Adv Med Sci 2015 Mar 9;60(1):76-82. Epub 2014 Dec 9.

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.advms.2014.11.002DOI Listing
March 2015

Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.

Neurobiol Aging 2015 Feb 31;36(2):601-7. Epub 2014 Oct 31.

Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurobiolaging.2014.10.031DOI Listing
February 2015

Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease.

J Alzheimers Dis 2014 ;40(2):351-7

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-131634DOI Listing
January 2015

Plasma concentrations of the amyloid-β peptides in young volunteers: the influence of the APOE genotype.

J Alzheimers Dis 2014 ;40(4):1055-60

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-132687DOI Listing
January 2015

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.

Alzheimers Dement 2015 Jan 3;11(1):58-69. Epub 2014 May 3.

Institute for Memory and Alzheimer's Disease, Institute of Neurology, Pitié-Salpêtrière Hospital Group, Pierre and Marie Curie University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2014.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386839PMC
January 2015

Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Aβ peptides.

Neurobiol Dis 2015 Jan 7;73:24-35. Epub 2014 Sep 7.

Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University of Erlangen-Nuremberg, Schwabachanlage 6, D-91054 Erlangen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2014.08.031DOI Listing
January 2015

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.

Alzheimers Dement 2014 Nov 20;10(6):808-17. Epub 2014 Aug 20.

Centre for Memory Disturbances and Alzheimer's Centre, Section of Neurology, University of Perugia, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2014.03.003DOI Listing
November 2014

Neuroprotein dynamics in the cerebrospinal fluid: intraindividual concomitant ventricular and lumbar measurements.

Eur Neurol 2013 17;70(3-4):189-94. Epub 2013 Aug 17.

Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000352032DOI Listing
June 2014

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS).

J Neural Transm (Vienna) 2014 May 24;121(5):469-77. Epub 2013 Dec 24.

Department of Biochemical Diagnostics, Medical University of Białystok, Białystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-013-1143-5DOI Listing
May 2014

Characterization of acid sphingomyelinase activity in human cerebrospinal fluid.

PLoS One 2013 2;8(5):e62912. Epub 2013 May 2.

Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0062912PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642176PMC
December 2013

The influence of insulin infusion on the metabolism of amyloid β peptides in plasma.

Alzheimers Dement 2013 Jul 27;9(4):400-5. Epub 2012 Oct 27.

Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Białystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2012.01.013DOI Listing
July 2013

Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease.

Biochem Pharmacol 2013 Jul 3;86(1):37-42. Epub 2013 Jan 3.

Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2012.12.007DOI Listing
July 2013

Assessment of the effects of adjunctive gabapentin on postoperative pain after intervertebral disc surgery in dogs.

Vet Anaesth Analg 2012 Nov 10;39(6):636-46. Epub 2012 Aug 10.

Small Animal Clinic, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1467-2995.2012.00769.xDOI Listing
November 2012

Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease.

J Neurochem 2012 Oct 23;123(2):310-6. Epub 2012 Aug 23.

Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1471-4159.2012.07893.xDOI Listing
October 2012

Neurochemical dementia diagnostics for Alzheimer's disease and other dementias: an ISO 15189 perspective.

Biomark Med 2012 Oct;6(5):685-90

Department of Psychiatry & Psychotherapy, Universitätsklinikum Erlangen & Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm.12.63DOI Listing
October 2012

Cerebrospinal fluid soluble amyloid-β protein precursor as a potential novel biomarkers of Alzheimer's disease.

J Alzheimers Dis 2012 ;28(1):119-25

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-2011-110857DOI Listing
September 2012

Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: a pilot study.

J Neural Transm (Vienna) 2012 Jul 14;119(7):779-88. Epub 2012 Mar 14.

Department of Physiology, Faculty of Medicine, Jabriya, Kuwait University, P.O. Box 24923, Safat, 13110, Kuwait.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-012-0781-3DOI Listing
July 2012

CSF markers in amyotrophic lateral sclerosis.

J Neural Transm (Vienna) 2012 Jul 4;119(7):747-57. Epub 2012 May 4.

Department of Neurology, Medical University of Bialystok, Bialystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-012-0806-yDOI Listing
July 2012

Increased concentration of the CSF Tau protein and its phosphorylated form in the late juvenile metachromatic leukodystrophy form: a case report.

J Neural Transm (Vienna) 2012 Jul 24;119(7):759-62. Epub 2012 May 24.

Department of Neurology, Medical University of Bialystok, Bialystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-012-0826-7DOI Listing
July 2012

Plasma amyloid-beta peptides in acute cerebral ischemia: a pilot study.

J Clin Lab Anal 2012 Jul;26(4):238-45

Department of Psychiatry, Psychotherapy and Addiction Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen, Henricistrasse 92, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcla.21511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807547PMC
July 2012

The pros and cons of multiplexing: a guest-editor's introduction.

Authors:
Piotr Lewczuk

Methods 2012 Apr;56(4):461-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2012.06.001DOI Listing
April 2012

Nuclear medicine diagnostic techniques in the era of pathophysiology-based CSF biomarkers for Alzheimer's disease.

J Alzheimers Dis 2011 ;26 Suppl 3:97-103

Department for Psychiatry and Psychiatry, University of Erlangen-Nurenberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-2011-0020DOI Listing
February 2012

Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.

J Alzheimers Dis 2011 ;26(2):207-10

Department of Psychiatry and Psychotherapy, Klinikum der Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-2011-110356DOI Listing
January 2012

Transient increase of plasma concentrations of amyloid β peptides after electroconvulsive therapy.

Brain Stimul 2012 Jan 12;5(1):25-9. Epub 2011 Mar 12.

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brs.2011.01.007DOI Listing
January 2012

Preanalytical sample handling and sample stability testing for the neurochemical dementia diagnostics.

J Alzheimers Dis 2011 ;25(4):739-45

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-2011-110212DOI Listing
November 2011

Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?

Expert Rev Proteomics 2011 Aug;8(4):447-58

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen and Friedrich-Alexander Universität Erlangen-Nürnberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/epr.11.37DOI Listing
August 2011

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.

Alzheimers Dement 2011 Jul;7(4):386-395.e6

Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2011.05.2243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710290PMC
July 2011

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.

Dement Geriatr Cogn Disord 2011 7;31(1):37-44. Epub 2010 Dec 7.

Department of Psychiatry, Psychotherapy and Addiction Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000322370DOI Listing
May 2011

Cerebrospinal fluid leakage--reliable diagnostic methods.

Clin Chim Acta 2011 May 17;412(11-12):837-40. Epub 2011 Feb 17.

Department of Clinical Laboratory Diagnostics, Medical University, Białystok, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2011.02.017DOI Listing
May 2011

Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension.

Hypertens Res 2011 Apr 13;34(4):484-8. Epub 2011 Jan 13.

Department of Cardiology/Medical Clinic II, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/hr.2010.258DOI Listing
April 2011

Cerebrospinal fluid under non-steady state condition caused by plasmapheresis.

J Neural Transm (Vienna) 2011 Feb 16;118(2):219-22. Epub 2010 Nov 16.

Department of Neurology, Universitätsklinikum Erlangen, Schwabachanlage 6, 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-010-0519-zDOI Listing
February 2011

Perfusion Imaging with SPECT in the Era of Pathophysiology-Based Biomarkers for Alzheimer's Disease.

Int J Alzheimers Dis 2010 Dec 15;2010:109618. Epub 2010 Dec 15.

Department for Psychiatry and Psychiatry, University of Erlangen-Nuermberg, Schwabachanlage 6, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4061/2010/109618DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010620PMC
December 2010

Confirmation rate of blinded (99m)Tc-SPECT compared to neurochemical dementia biomarkers in CSF in patients with Alzheimer disease.

J Neural Transm (Vienna) 2010 Sep 7;117(9):1111-4. Epub 2010 Aug 7.

Clinical Nuclear Medicine Unit, University of Erlangen-Nurenberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-010-0459-7DOI Listing
September 2010

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.

Int J Alzheimers Dis 2010 Sep 19;2010. Epub 2010 Sep 19.

Laboratory for Molecular Neurobiology, Department of Psychiatry and Psychotherapy, University of Duisburg-Essen, LVR-Klinikum Essen, Virchowstraße 174, 45147 Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4061/2010/548145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945639PMC
September 2010

Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia.

Int J Alzheimers Dis 2010 Aug 24;2010. Epub 2010 Aug 24.

Department of Psychiatry, Psychotherapy and Addiction Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen, Henricistrasse 92, 45136 Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4061/2010/761571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938459PMC
August 2010

Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics.

J Alzheimers Dis 2010 ;19(4):1199-203

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-2010-1313DOI Listing
July 2010

Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma.

Am J Pathol 2010 Jun 15;176(6):2868-79. Epub 2010 Apr 15.

Department of Ophthalmology, University of Erlangen-Nürnberg, Schwabachanlage 6, D-91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2010.090914DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877848PMC
June 2010

Neurofilament ELISA validation.

J Immunol Methods 2010 Jan 24;352(1-2):23-31. Epub 2009 Oct 24.

Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2009.09.014DOI Listing
January 2010